Global Cancer Monoclonal Antibodies Market Professional Survey Report 2017

  • KMI-168039
  • Sep 2017
  • 113 pages
  • Pharmaceutical
This report studies Cancer Monoclonal Antibodies in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
Pfizer
Merck
Eli Lilly
Sanofi
Janssen Biotech
Novartis
AbbVie
Boehringer Ingelheim
AstraZeneca
Bayer
Biogen
TG Therapeutics
CTI BioPharma
Intas Pharmaceuticals
Kyowa Hakko Kirin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Naked mAbs
Conjugated mAbs

By Application, the market can be split into
Hospitals
Retail Pharmacies

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Cancer Monoclonal Antibodies Market Professional Survey Report 2017
1 Industry Overview of Cancer Monoclonal Antibodies
1.1 Definition and Specifications of Cancer Monoclonal Antibodies
1.1.1 Definition of Cancer Monoclonal Antibodies
1.1.2 Specifications of Cancer Monoclonal Antibodies
1.2 Classification of Cancer Monoclonal Antibodies
1.2.1 Naked mAbs
1.2.2 Conjugated mAbs
1.3 Applications of Cancer Monoclonal Antibodies
1.3.1 Hospitals
1.3.2 Retail Pharmacies
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Cancer Monoclonal Antibodies
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer Monoclonal Antibodies
2.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies
2.4 Industry Chain Structure of Cancer Monoclonal Antibodies

3 Technical Data and Manufacturing Plants Analysis of Cancer Monoclonal Antibodies
3.1 Capacity and Commercial Production Date of Global Cancer Monoclonal Antibodies Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Cancer Monoclonal Antibodies Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Cancer Monoclonal Antibodies Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Cancer Monoclonal Antibodies Major Manufacturers in 2016

4 Global Cancer Monoclonal Antibodies Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Cancer Monoclonal Antibodies Capacity and Growth Rate Analysis
4.2.2 2016 Cancer Monoclonal Antibodies Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Cancer Monoclonal Antibodies Sales and Growth Rate Analysis
4.3.2 2016 Cancer Monoclonal Antibodies Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Cancer Monoclonal Antibodies Sales Price
4.4.2 2016 Cancer Monoclonal Antibodies Sales Price Analysis (Company Segment)

5 Cancer Monoclonal Antibodies Regional Market Analysis
5.1 North America Cancer Monoclonal Antibodies Market Analysis
5.1.1 North America Cancer Monoclonal Antibodies Market Overview
5.1.2 North America 2012-2017E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Cancer Monoclonal Antibodies Sales Price Analysis
5.1.4 North America 2016 Cancer Monoclonal Antibodies Market Share Analysis
5.2 China Cancer Monoclonal Antibodies Market Analysis
5.2.1 China Cancer Monoclonal Antibodies Market Overview
5.2.2 China 2012-2017E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Cancer Monoclonal Antibodies Sales Price Analysis
5.2.4 China 2016 Cancer Monoclonal Antibodies Market Share Analysis
5.3 Europe Cancer Monoclonal Antibodies Market Analysis
5.3.1 Europe Cancer Monoclonal Antibodies Market Overview
5.3.2 Europe 2012-2017E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Cancer Monoclonal Antibodies Sales Price Analysis
5.3.4 Europe 2016 Cancer Monoclonal Antibodies Market Share Analysis
5.4 Southeast Asia Cancer Monoclonal Antibodies Market Analysis
5.4.1 Southeast Asia Cancer Monoclonal Antibodies Market Overview
5.4.2 Southeast Asia 2012-2017E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Cancer Monoclonal Antibodies Sales Price Analysis
5.4.4 Southeast Asia 2016 Cancer Monoclonal Antibodies Market Share Analysis
5.5 Japan Cancer Monoclonal Antibodies Market Analysis
5.5.1 Japan Cancer Monoclonal Antibodies Market Overview
5.5.2 Japan 2012-2017E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Cancer Monoclonal Antibodies Sales Price Analysis
5.5.4 Japan 2016 Cancer Monoclonal Antibodies Market Share Analysis
5.6 India Cancer Monoclonal Antibodies Market Analysis
5.6.1 India Cancer Monoclonal Antibodies Market Overview
5.6.2 India 2012-2017E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Cancer Monoclonal Antibodies Sales Price Analysis
5.6.4 India 2016 Cancer Monoclonal Antibodies Market Share Analysis

6 Global 2012-2017E Cancer Monoclonal Antibodies Segment Market Analysis (by Type)
6.1 Global 2012-2017E Cancer Monoclonal Antibodies Sales by Type
6.2 Different Types of Cancer Monoclonal Antibodies Product Interview Price Analysis
6.3 Different Types of Cancer Monoclonal Antibodies Product Driving Factors Analysis
6.3.1 Naked mAbs of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
6.3.2 Conjugated mAbs of Cancer Monoclonal Antibodies Growth Driving Factor Analysis

7 Global 2012-2017E Cancer Monoclonal Antibodies Segment Market Analysis (by Application)
7.1 Global 2012-2017E Cancer Monoclonal Antibodies Consumption by Application
7.2 Different Application of Cancer Monoclonal Antibodies Product Interview Price Analysis
7.3 Different Application of Cancer Monoclonal Antibodies Product Driving Factors Analysis
7.3.1 Hospitals of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.2 Retail Pharmacies of Cancer Monoclonal Antibodies Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Cancer Monoclonal Antibodies
8.1 F. Hoffmann-La Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 F. Hoffmann-La Roche 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 F. Hoffmann-La Roche 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Amgen 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.3 Bristol-Myers Squibb
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Bristol-Myers Squibb 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Bristol-Myers Squibb 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.4 Takeda Pharmaceuticals
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Takeda Pharmaceuticals 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Takeda Pharmaceuticals 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Pfizer 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.6 Merck
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Merck 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Merck 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.7 Eli Lilly
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Eli Lilly 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Eli Lilly 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.8 Sanofi
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Sanofi 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Sanofi 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.9 Janssen Biotech
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Janssen Biotech 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Janssen Biotech 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.10 Novartis
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Novartis 2016 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Novartis 2016 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.11 AbbVie
8.12 Boehringer Ingelheim
8.13 AstraZeneca
8.14 Bayer
8.15 Biogen
8.16 TG Therapeutics
8.17 CTI BioPharma
8.18 Intas Pharmaceuticals
8.19 Kyowa Hakko Kirin

9 Development Trend of Analysis of Cancer Monoclonal Antibodies Market
9.1 Global Cancer Monoclonal Antibodies Market Trend Analysis
9.1.1 Global 2017-2022 Cancer Monoclonal Antibodies Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Cancer Monoclonal Antibodies Sales Price Forecast
9.2 Cancer Monoclonal Antibodies Regional Market Trend
9.2.1 North America 2017-2022 Cancer Monoclonal Antibodies Consumption Forecast
9.2.2 China 2017-2022 Cancer Monoclonal Antibodies Consumption Forecast
9.2.3 Europe 2017-2022 Cancer Monoclonal Antibodies Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Cancer Monoclonal Antibodies Consumption Forecast
9.2.5 Japan 2017-2022 Cancer Monoclonal Antibodies Consumption Forecast
9.2.6 India 2017-2022 Cancer Monoclonal Antibodies Consumption Forecast
9.3 Cancer Monoclonal Antibodies Market Trend (Product Type)
9.4 Cancer Monoclonal Antibodies Market Trend (Application)

10 Cancer Monoclonal Antibodies Marketing Type Analysis
10.1 Cancer Monoclonal Antibodies Regional Marketing Type Analysis
10.2 Cancer Monoclonal Antibodies International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Cancer Monoclonal Antibodies by Region
10.4 Cancer Monoclonal Antibodies Supply Chain Analysis

11 Consumers Analysis of Cancer Monoclonal Antibodies
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
?

12 Conclusion of the Global Cancer Monoclonal Antibodies Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Head-Sales
mansing
Mansingh Surve
Manager-Sales
Vivek
Vivek Pandey
Assistant Manager-Sales
Roshnee
Roshnee Tendulkar
Team Lead-Sales
view